These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 32252777)

  • 1. The NLRP3 inflammasome in traumatic brain injury: potential as a biomarker and therapeutic target.
    O'Brien WT; Pham L; Symons GF; Monif M; Shultz SR; McDonald SJ
    J Neuroinflammation; 2020 Apr; 17(1):104. PubMed ID: 32252777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NLRP3 inflammasome in traumatic brain injury: Its implication in the disease pathophysiology and potential as a therapeutic target.
    Chakraborty R; Tabassum H; Parvez S
    Life Sci; 2023 Feb; 314():121352. PubMed ID: 36592789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of NLRP3 Inflammasome in the Pathogenesis of Traumatic Brain Injury.
    Irrera N; Russo M; Pallio G; Bitto A; Mannino F; Minutoli L; Altavilla D; Squadrito F
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel small molecular NLRP3 inflammasome inhibitor alleviates neuroinflammatory response following traumatic brain injury.
    Kuwar R; Rolfe A; Di L; Xu H; He L; Jiang Y; Zhang S; Sun D
    J Neuroinflammation; 2019 Apr; 16(1):81. PubMed ID: 30975164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 Tat Primes and Activates Microglial NLRP3 Inflammasome-Mediated Neuroinflammation.
    Chivero ET; Guo ML; Periyasamy P; Liao K; Callen SE; Buch S
    J Neurosci; 2017 Mar; 37(13):3599-3609. PubMed ID: 28270571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small molecule inhibitors of NLRP3 inflammasome and GSK-3β in the management of traumatic brain injury: A review.
    Shaik MG; Joshi SV; Akunuri R; Rana P; Rahman Z; Polomoni A; Yaddanapudi VM; Dandekar MP; Srinivas N
    Eur J Med Chem; 2023 Nov; 259():115718. PubMed ID: 37573828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium houttuyfonate attenuates neurological defects after traumatic brain injury in mice via inhibiting NLRP3 inflammasomes.
    Yao X; Wang S; Chen Y; Sheng L; Li H; You H; Ye J; Zhang Q; Li J
    J Biochem Mol Toxicol; 2021 Sep; 35(9):e22850. PubMed ID: 34405489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIF-1α aggravated traumatic brain injury by NLRP3 inflammasome-mediated pyroptosis and activation of microglia.
    Yuan D; Guan S; Wang Z; Ni H; Ding D; Xu W; Li G
    J Chem Neuroanat; 2021 Oct; 116():101994. PubMed ID: 34166779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telmisartan reduced cerebral edema by inhibiting NLRP3 inflammasome in mice with cold brain injury.
    Wei X; Hu CC; Zhang YL; Yao SL; Mao WK
    J Huazhong Univ Sci Technolog Med Sci; 2016 Aug; 36(4):576-583. PubMed ID: 27465336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
    Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
    Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NADPH Oxidase 2 Regulates NLRP3 Inflammasome Activation in the Brain after Traumatic Brain Injury.
    Ma MW; Wang J; Dhandapani KM; Brann DW
    Oxid Med Cell Longev; 2017; 2017():6057609. PubMed ID: 28785377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration of Dexmedetomidine inhibited NLRP3 inflammasome and microglial cell activities in hippocampus of traumatic brain injury rats.
    Zheng B; Zhang S; Ying Y; Guo X; Li H; Xu L; Ruan X
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30232232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol pretreatment attenuates traumatic brain injury in rats by suppressing NLRP3 inflammasome activation via SIRT1.
    Zou P; Liu X; Li G; Wang Y
    Mol Med Rep; 2018 Feb; 17(2):3212-3217. PubMed ID: 29257276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the interaction between microglial adenosine 2A receptor and NLRP3 inflammasome attenuates neuroinflammation posttraumatic brain injury.
    Du H; Li CH; Gao RB; Tan Y; Wang B; Peng Y; Yang N; Ning YL; Li P; Zhao Y; Zhou YG
    CNS Neurosci Ther; 2024 Jan; 30(1):e14408. PubMed ID: 37564004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EK7 Regulates NLRP3 Inflammasome Activation and Neuroinflammation Post-traumatic Brain Injury.
    Chen Y; Meng J; Bi F; Li H; Chang C; Ji C; Liu W
    Front Mol Neurosci; 2019; 12():202. PubMed ID: 31555089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of autophagy in microglia and macrophages exacerbates innate immune responses and worsens brain injury outcomes.
    Hegdekar N; Sarkar C; Bustos S; Ritzel RM; Hanscom M; Ravishankar P; Philkana D; Wu J; Loane DJ; Lipinski MM
    Autophagy; 2023 Jul; 19(7):2026-2044. PubMed ID: 36652438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 Viral Protein R Activates NLRP3 Inflammasome in Microglia: implications for HIV-1 Associated Neuroinflammation.
    Mamik MK; Hui E; Branton WG; McKenzie BA; Chisholm J; Cohen EA; Power C
    J Neuroimmune Pharmacol; 2017 Jun; 12(2):233-248. PubMed ID: 27726055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MCC950, the Selective Inhibitor of Nucleotide Oligomerization Domain-Like Receptor Protein-3 Inflammasome, Protects Mice against Traumatic Brain Injury.
    Ismael S; Nasoohi S; Ishrat T
    J Neurotrauma; 2018 Jun; 35(11):1294-1303. PubMed ID: 29295651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The NLRP3 inflammasome: a potential therapeutic target for traumatic brain injury.
    Ismael S; Ahmed HA; Adris T; Parveen K; Thakor P; Ishrat T
    Neural Regen Res; 2021 Jan; 16(1):49-57. PubMed ID: 32788447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pathogenic role of the inflammasome in neurodegenerative diseases.
    Freeman LC; Ting JP
    J Neurochem; 2016 Jan; 136 Suppl 1():29-38. PubMed ID: 26119245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.